Geron could resume stem cell trial

Geron Corp., a Menlo Park-based stem cell research company, has moved closer to a federal approval that would allow it to resume its testing of an embryonic stem cell therapy for spinal cord injuries. While the U.S. Food and Drug Administration …

[Read the full article here]

Leave a Reply